Free Trial

Illumina (ILMN) Competitors

Illumina logo
$101.80 +2.51 (+2.53%)
Closing price 08/22/2025 04:00 PM Eastern
Extended Trading
$102.58 +0.78 (+0.77%)
As of 08/22/2025 07:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ILMN vs. A, MTD, WAT, TECH, CRL, BIO, BRKR, PACB, HBIO, and TMO

Should you be buying Illumina stock or one of its competitors? The main competitors of Illumina include Agilent Technologies (A), Mettler-Toledo International (MTD), Waters (WAT), Bio-Techne (TECH), Charles River Laboratories International (CRL), Bio-Rad Laboratories (BIO), Bruker (BRKR), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), and Thermo Fisher Scientific (TMO). These companies are all part of the "life sciences tools & services" industry.

Illumina vs. Its Competitors

Illumina (NASDAQ:ILMN) and Agilent Technologies (NYSE:A) are both large-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, risk, dividends, earnings, media sentiment and valuation.

Illumina presently has a consensus target price of $124.58, suggesting a potential upside of 22.38%. Agilent Technologies has a consensus target price of $139.77, suggesting a potential upside of 15.04%. Given Illumina's higher probable upside, equities research analysts plainly believe Illumina is more favorable than Agilent Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Illumina
2 Sell rating(s)
11 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.25
Agilent Technologies
0 Sell rating(s)
6 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.54

Illumina has a beta of 1.37, indicating that its share price is 37% more volatile than the S&P 500. Comparatively, Agilent Technologies has a beta of 1.22, indicating that its share price is 22% more volatile than the S&P 500.

In the previous week, Agilent Technologies had 10 more articles in the media than Illumina. MarketBeat recorded 27 mentions for Agilent Technologies and 17 mentions for Illumina. Illumina's average media sentiment score of 1.65 beat Agilent Technologies' score of 1.33 indicating that Illumina is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Illumina
17 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Agilent Technologies
21 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Agilent Technologies has higher revenue and earnings than Illumina. Illumina is trading at a lower price-to-earnings ratio than Agilent Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Illumina$4.37B3.58-$1.22B$7.9012.89
Agilent Technologies$6.63B5.21$1.29B$4.0530.00

89.4% of Illumina shares are held by institutional investors. Comparatively, 87.4% of Agilent Technologies shares are held by institutional investors. 2.6% of Illumina shares are held by company insiders. Comparatively, 0.3% of Agilent Technologies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Illumina has a net margin of 29.36% compared to Agilent Technologies' net margin of 17.59%. Illumina's return on equity of 28.93% beat Agilent Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Illumina29.36% 28.93% 10.74%
Agilent Technologies 17.59%25.92%13.24%

Summary

Illumina beats Agilent Technologies on 8 of the 15 factors compared between the two stocks.

Get Illumina News Delivered to You Automatically

Sign up to receive the latest news and ratings for ILMN and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ILMN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ILMN vs. The Competition

MetricIlluminaMED IndustryMedical SectorNASDAQ Exchange
Market Cap$15.26B$3.11B$5.76B$9.58B
Dividend YieldN/A2.23%4.41%4.10%
P/E Ratio12.8920.8831.1026.04
Price / Sales3.58343.33433.45102.77
Price / Cash21.1743.1937.7358.48
Price / Book6.938.129.536.61
Net Income-$1.22B-$54.72M$3.26B$265.56M
7 Day Performance1.69%2.63%2.10%1.97%
1 Month Performance-2.69%2.78%2.81%-0.36%
1 Year Performance-22.52%11.01%30.56%19.03%

Illumina Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ILMN
Illumina
4.6591 of 5 stars
$101.80
+2.5%
$124.58
+22.4%
-21.3%$15.26B$4.37B12.899,030Positive News
A
Agilent Technologies
4.9473 of 5 stars
$118.44
-0.6%
$139.77
+18.0%
-13.4%$33.65B$6.51B29.2417,900News Coverage
Positive News
Upcoming Earnings
MTD
Mettler-Toledo International
4.005 of 5 stars
$1,315.45
+0.2%
$1,288.89
-2.0%
-7.4%$27.10B$3.87B33.3117,300Positive News
Analyst Forecast
Insider Trade
WAT
Waters
4.7897 of 5 stars
$289.15
-0.8%
$378.73
+31.0%
-10.2%$17.21B$3.05B26.077,600Trending News
TECH
Bio-Techne
4.8196 of 5 stars
$53.29
-0.6%
$69.42
+30.3%
-20.0%$8.35B$1.22B115.853,100Positive News
Dividend Announcement
Analyst Upgrade
CRL
Charles River Laboratories International
4.0293 of 5 stars
$157.27
+0.4%
$175.69
+11.7%
-19.7%$7.74B$4.05B-118.2520,100News Coverage
Positive News
Insider Trade
BIO
Bio-Rad Laboratories
4.5746 of 5 stars
$284.39
-0.4%
$333.50
+17.3%
-2.3%$7.70B$2.57B24.247,700Positive News
Analyst Downgrade
BRKR
Bruker
4.9699 of 5 stars
$34.24
+2.1%
$51.30
+49.8%
-44.2%$5.19B$3.37B65.8511,396
PACB
Pacific Biosciences of California
2.2663 of 5 stars
$1.33
+1.5%
$1.90
+42.9%
-4.2%$399.49M$154.01M-0.58730Positive News
HBIO
Harvard Bioscience
3.8575 of 5 stars
$0.50
-4.6%
$3.00
+494.4%
-82.8%$22.48M$88.75M-0.39490Gap Up
TMO
Thermo Fisher Scientific
4.9163 of 5 stars
$488.15
-0.2%
$593.00
+21.5%
-17.2%$184.33B$42.88B28.23125,000Trending News
Insider Trade
Analyst Revision

Related Companies and Tools


This page (NASDAQ:ILMN) was last updated on 8/23/2025 by MarketBeat.com Staff
From Our Partners